Financials
Reported figures only · latest: Q4 2025
DKK · IFRS
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income12 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | DKK 309.1B | DKK 102.4B |
|---|
| FY24 | DKK 290.4B | DKK 101B |
|---|
| FY23 | DKK 232.3B | DKK 83.7B |
|---|
| FY22 | DKK 177B | DKK 55.5B |
|---|
| FY21 | DKK 140.8B | DKK 47.8B |
|---|
| FY20 | DKK 126.9B | DKK 42.1B |
|---|
| FY19 | DKK 122B | DKK 39B |
|---|
| FY18 | DKK 111.8B | DKK 38.6B |
|---|
| FY17 | DKK 111.7B | DKK 38.1B |
|---|
| FY16 | DKK 111.8B | DKK 37.9B |
|---|
| FY15 | DKK 107.9B | DKK 34.9B |
|---|
| FY14 | - | - |
|---|
MarginsShare of revenue- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|
| FY25 | 81% | 41.3% | 33.1% |
|---|
| FY24 | 84.7% | 44.2% | 34.8% |
|---|
| FY23 | 84.6% | 44.2% | 36% |
|---|
| FY22 | 83.9% | 42.3% | 31.4% |
|---|
| FY21 | 83.2% | 41.7% | 33.9% |
|---|
| FY20 | 83.5% | 42.6% | 33.2% |
|---|
| FY19 | 83.5% | 43% | 31.9% |
|---|
| FY18 | 84.2% | 42.2% | 34.5% |
|---|
| FY17 | 84.2% | 43.8% | 34.1% |
|---|
| FY16 | 84.6% | 43.3% | 33.9% |
|---|
| FY15 | 85% | 45.8% | 32.3% |
|---|
| FY14 | - | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | DKK 59B |
|---|
| FY24 | DKK 73.8B |
|---|
| FY23 | DKK 83.1B |
|---|
| FY22 | DKK 66.7B |
|---|
| FY21 | DKK 48.7B |
|---|
| FY20 | DKK 46.1B |
|---|
| FY19 | DKK 37.9B |
|---|
| FY18 | DKK 35B |
|---|
| FY17 | DKK 33.5B |
|---|
| FY16 | DKK 41.2B |
|---|
| FY15 | DKK 33.1B |
|---|
| FY14 | - |
|---|
Returned to shareholdersDividends paid and shares bought backShow the numbers
| Year | Dividends | Buybacks |
|---|
| FY25 | DKK 51.8B | DKK 1.4B |
|---|
| FY24 | DKK 44.1B | DKK 20.2B |
|---|
| FY23 | DKK 31.8B | DKK 29.9B |
|---|
| FY22 | DKK 25.3B | DKK 24.1B |
|---|
| FY21 | DKK 21.5B | DKK 19.4B |
|---|
| FY20 | DKK 20.1B | DKK 16.9B |
|---|
| FY19 | DKK 19.4B | DKK 15.3B |
|---|
| FY18 | DKK 19B | DKK 15.6B |
|---|
| FY17 | DKK 18.8B | DKK 16.8B |
|---|
| FY16 | DKK 23.8B | DKK 15.1B |
|---|
| FY15 | DKK 12.9B | DKK 17.2B |
|---|
| FY14 | - | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SEC- Novo Nordisk A S
- Healthcare median
Show the numbers
| Year | Novo Nordisk A S | Healthcare median |
|---|
| FY25 | 33.1% | −30.6% |
|---|
| FY24 | 34.8% | −47% |
|---|
| FY23 | 36% | −58% |
|---|
| FY22 | 31.4% | −80.4% |
|---|
| FY21 | 33.9% | −71.9% |
|---|
| FY20 | 33.2% | −62.2% |
|---|
| FY19 | 31.9% | −46.3% |
|---|
| FY18 | 34.5% | −49.6% |
|---|
| FY17 | 34.1% | −45.9% |
|---|
| FY16 | 33.9% | −36% |
|---|
| FY15 | 32.3% | −38.4% |
|---|
| FY14 | - | −35.5% |
|---|